Element Nutritional Sciences Inc (TSE:MUSL) has released an update.
Promino Nutritional Sciences Inc. has partnered with renowned chemist Dr. Patrick Gunning to conduct preclinical studies of its patented amino acid formula aimed at reducing muscle loss in cancer patients. The company’s initiative, led by the expertise of Professor Gunning, reflects a commitment to advancing personalized nutritional interventions to improve the quality of life and treatment outcomes for cancer sufferers. With the health industry’s shift towards personalized medicine, Promino is at the forefront with its specifically designed nutraceutical supplements.
For further insights into TSE:MUSL stock, check out TipRanks’ Stock Analysis page.
